Virax Biolabs Group Limited (VRAX) Stock Forecast
VRAX analyst forecast
as of October 18, 2026- Analyst consensus
- —
- Price target
- $25.00 average of analyst targets
- Upside to target
- +1,624.1% from the latest close
- Next earnings
- —
- 52-week range
- $1.45 – $17.20
VRAX price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
VRAX earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Next quarter (Sep '26) | −$1.75 | −$1.75 | −$1.75 | — | — | 1 |
| Current fiscal year (FY2027) | −$6.00 | −$6.00 | −$6.00 | −$12.64 | +52.5% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
VRAX revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Next quarter (Sep '26) | $0 | $0 | $0 | — | — |
| Current fiscal year (FY2027) | $4,000 | $4,000 | $4,000 | −67.8% | 1 |
VRAX EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
VRAX revenue: reported and forecast
VRAX EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Next quarter (Sep '26) | $0.00 | $0.00 | $0.00 | $0.00 | −$1.75 | — | 0 up · 0 down |
| Current fiscal year (FY2027) | $0.00 | $0.00 | $0.00 | $0.00 | −$6.00 | — | 0 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
VRAX earnings surprises
Reported EPS vs the consensus estimate for the last 4 quarters; VRAX beat in 0 of 4.
What analysts expect from VRAX
The average price target is $25.00, 1,624.1% above the latest close of $1.45. Analysts expect earnings of −$6.00 per share for FY2027, +52.5% from a year earlier. Virax Biolabs beat the EPS estimate in 0 of the last 4 quarters.
Related: VRAX income statement, VRAX key metrics, VRAX chart. See the VRAX stock overview for the latest quote and news.
VRAX forecast FAQ
What is Virax Biolabs's price target?
The average analyst price target for Virax Biolabs is $25.00, 1,624.1% above the latest close of $1.45.
What is Virax Biolabs's EPS forecast?
Analysts forecast −$6.00 per share for FY2027 (range −$6.00 to −$6.00).
What is Virax Biolabs's revenue forecast?
The average revenue estimate for FY2027 is $0.0 million, growth of −67.8%.
Does Virax Biolabs usually beat earnings estimates?
Virax Biolabs reported EPS at or above the analyst estimate in 0 of the last 4 quarters.